| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1988PNAS...85..910Z |
| P356 | DOI | 10.1073/PNAS.85.3.910 |
| P932 | PMC publication ID | 279666 |
| P698 | PubMed publication ID | 3277183 |
| P5875 | ResearchGate publication ID | 19879492 |
| P2093 | author name string | Martin B | |
| Chen HC | |||
| Zasloff M | |||
| P2860 | cites work | Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor | Q24569680 |
| A novel peptide designated PYLa and its precursor as predicted from cloned mRNA of Xenopus laevis skin | Q33933506 | ||
| Three-dimensional structure of membrane and surface proteins | Q34258165 | ||
| Xenopsin: the neurotensin-like octapeptide from Xenopus skin at the carboxyl terminus of its precursor | Q36246933 | ||
| Solid-phase synthesis of PYLa and isolation of its natural counterpart, PGLa [PYLa-(4-24)] from skin secretion of Xenopus laevis. | Q36485325 | ||
| Reduction of sulfoxides in peptides and proteins | Q39303712 | ||
| Peptides with affinity for membranes | Q39657761 | ||
| Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones | Q42855733 | ||
| Biosynthesis of peptides in the skin of Xenopus laevis: isolation of novel peptides predicted from the sequence of cloned cDNAs | Q43500383 | ||
| Novel peptide fragments originating from PGLa and the caerulein and xenopsin precursors from Xenopus laevis | Q46867138 | ||
| A microchemical facility for the analysis and synthesis of genes and proteins | Q71402210 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 910-913 | |
| P577 | publication date | 1988-02-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Antimicrobial activity of synthetic magainin peptides and several analogues | |
| P478 | volume | 85 |
| Q61685390 | A colorimetric assay for rapid screening of antimicrobial peptides |
| Q45337697 | A defensin from tomato with dual function in defense and development |
| Q40286806 | Ability of cecropin B to penetrate the enterobacterial outer membrane |
| Q48135516 | Accelerated molecular dynamics simulation analysis of MSI-594 in a lipid bilayer. |
| Q34776684 | Activity determinants of helical antimicrobial peptides: a large-scale computational study |
| Q33260522 | Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora |
| Q42130359 | Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains |
| Q35403079 | Agents that increase the permeability of the outer membrane. |
| Q37242308 | Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription |
| Q86886447 | Analysis of the flexibility and stability of the structure of magainin in a bilayer, and in aqueous and nonaqueous solutions using molecular dynamics simulations |
| Q73054859 | Anti-nidatory effect of vaginally administered (Ala8,13, 18)-magainin II amide in the rhesus monkey |
| Q41441235 | Antibacterial activity identification of pCM19 and pCM12 derived from hGlyrichin |
| Q35053375 | Antibacterial studies of cationic polymers with alternating, random, and uniform backbones |
| Q58030986 | Antimicrobial Peptides |
| Q39779042 | Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin |
| Q52548779 | Antimicrobial activity of magainin analogues against anaerobic oral pathogens. |
| Q36959721 | Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida |
| Q38803962 | Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003-2015). |
| Q36275702 | Antimicrobial peptides (AMPs): peptide structure and mode of action |
| Q36203490 | Antimicrobial peptides as microbicidal contraceptives: prophecies for prophylactics--a mini review |
| Q72903748 | Antimicrobial peptides from the skin of a Korean frog, Rana rugosa |
| Q45746254 | Antiviral effects of synthetic membrane-active peptides on herpes simplex virus, type 1. |
| Q34077008 | Atomic force microscopy study of the effect of antimicrobial peptides on the cell envelope of Escherichia coli. |
| Q39867883 | Augmentation of the antibacterial activity of magainin by positive-charge chain extension |
| Q37223398 | Beyond NMR spectra of antimicrobial peptides: dynamical images at atomic resolution and functional insights |
| Q36259097 | Cationic antimicrobial peptide, magainin down-regulates secretion of pro-inflammatory cytokines by early placental cytotrophoblasts. |
| Q40284531 | Change of glutamic acid to lysine in a 13-residue antibacterial and hemolytic peptide results in enhanced antibacterial activity without increase in hemolytic activity |
| Q42908495 | Characterization of the structure and membrane interaction of the antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs. |
| Q47266793 | Co-administration of Antimicrobial Peptides (AMPs) EnhancesToll-like Receptor 4 (TLR4) Antagonist Activity of a Synthetic Glycolipid. |
| Q28362033 | Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin |
| Q73305006 | Concentration-dependent differential induction of necrosis or apoptosis by HIV-1 lytic peptide 1 |
| Q34148704 | Cupiennin 1d*: the cytolytic activity depends on the hydrophobic N-terminus and is modulated by the polar C-terminus |
| Q92629953 | Current trends in targeted therapy for drug-resistant infections |
| Q37412040 | Dermaseptins and magainins: antimicrobial peptides from frogs' skin-new sources for a promising spermicides microbicides-a mini review |
| Q71846872 | Design and synthesis of amphipathic antimicrobial peptides |
| Q92710999 | Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice |
| Q64263640 | Dimerization of Antimicrobial Peptides: A Promising Strategy to Enhance Antimicrobial Peptide Activity |
| Q74195029 | Effect of lysozyme or modified lysozyme fragments on DNA and RNA synthesis and membrane permeability of Escherichia coli |
| Q73614145 | Effect of magainin, class L, and class A amphipathic peptides on fatty acid spin labels in lipid bilayers |
| Q37277016 | Effect of membrane composition on antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs |
| Q35101392 | Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes |
| Q39874961 | Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga |
| Q35551490 | Effects of pH and salinity on the antimicrobial properties of clavanins |
| Q39865103 | Effects of two magainin peptides on eicosanoid release from rat peritoneal macrophages |
| Q34320603 | Electrical detection of pathogenic bacteria via immobilized antimicrobial peptides. |
| Q57952080 | Emerging drug treatments for cystic fibrosis |
| Q54537161 | Enhanced antitumor activity and selectivity of lactoferrin-derived peptides. |
| Q38665048 | Enhanced membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH |
| Q28289518 | Epithelial antimicrobial peptides: review and significance for oral applications |
| Q73470881 | Evaluation of the antifertility effect of magainin-A in rabbits: in vitro and in vivo studies |
| Q47637628 | Exploration of the forbidden regions of the Ramachandran plot (ϕ-ψ) with QTAIM. |
| Q53217564 | Foldamers as Anticancer Therapeutics: Targeting Protein-Protein Interactions and the Cell Membrane. |
| Q32086395 | Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease |
| Q33298468 | Global phenotype screening and transcript analysis outlines the inhibitory mode(s) of action of two amphibian-derived, alpha-helical, cationic peptides on Saccharomyces cerevisiae |
| Q44602283 | Helical Peptoid Mimics of Magainin-2 Amide |
| Q38194189 | Helicobacter pylori infection: A brief overview on alternative natural treatments to conventional therapy. |
| Q37721706 | High antimicrobial effectiveness with low hemolytic and cytotoxic activity for PEG/quaternary copolyoxetanes |
| Q28659477 | Host-defense peptides with therapeutic potential from skin secretions of frogs from the family pipidae |
| Q41147373 | Hydrophobic mismatch demonstrated for membranolytic peptides, and their use as molecular rulers to measure bilayer thickness in native cells |
| Q35810626 | IL-22/STAT3-Induced Increases in SLURP1 Expression within Psoriatic Lesions Exerts Antimicrobial Effects against Staphylococcus aureus. |
| Q38528833 | Identification and characterization of the antimicrobial peptide corresponding to C-terminal beta-sheet domain of tenecin 1, an antibacterial protein of larvae of Tenebrio molitor |
| Q35328881 | Identification of novel peptides from amphibian (Xenopus tropicalis) skin by direct tissue MALDI-MS analysis |
| Q34250487 | Importance of residue 13 and the C-terminus for the structure and activity of the antimicrobial peptide aurein 2.2. |
| Q34992918 | In-vitro effects of the antimicrobial peptide Ala8,13,18-magainin II amide on isolated human first trimester villous trophoblast cells |
| Q35822539 | Inhibition of antibacterial activity of himastatin, a new antitumor antibiotic from Streptomyces hygroscopicus, by fatty acid sodium salts |
| Q36952873 | Insect antibacterial proteins: Not just for insects and against bacteria |
| Q51046016 | Interaction of multiple biomimetic antimicrobial polymers with model bacterial membranes. |
| Q46691769 | Interactions between Salmonella typhimurium lipopolysaccharide and the antimicrobial peptide, magainin 2 amide |
| Q54562301 | Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. |
| Q42406521 | Interactions of cationic-hydrophobic peptides with lipid bilayers: a Monte Carlo simulation method |
| Q64916330 | Isolation and characterization of an antibacterial peptide fraction from the pepsin hydrolysate of half-fin anchovy (Setipinna taty). |
| Q34422767 | Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder |
| Q35024514 | Iterative antimicrobial candidate selection from informed d-/l-Peptide dimer libraries |
| Q50562558 | Kinetic Pathway of Antimicrobial Peptide Magainin 2-Induced Pore Formation in Lipid Membranes |
| Q52543125 | Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin. |
| Q67593223 | Localization of xenopsin and xenopsin precursor fragment immunoreactivities in the skin and gastrointestinal tract of Xenopus laevis |
| Q57393965 | Magainin 2 amide and analogues Antimicrobial activity, membrane depolarization and susceptibility to proteolysis |
| Q30484999 | Magainin 2 in action: distinct modes of membrane permeabilization in living bacterial and mammalian cells |
| Q37260254 | Magainin 2 revisited: a test of the quantitative model for the all-or-none permeabilization of phospholipid vesicles |
| Q35274752 | Magainin analogs effective against pathogenic protozoa |
| Q41172599 | Magainins affect respiratory control, membrane potential and motility of hamster spermatozoa |
| Q34300587 | Magainins and the disruption of membrane-linked free-energy transduction |
| Q77521430 | Magainins as paradigm for the mode of action of pore forming polypeptides |
| Q61814874 | Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components |
| Q35269863 | Membrane interaction of antimicrobial peptides using E. coli lipid extract as model bacterial cell membranes and SFG spectroscopy |
| Q34735131 | Modulation of the activity of secretory phospholipase A2 by antimicrobial peptides |
| Q37415674 | Molecular interactions between magainin 2 and model membranes in situ |
| Q33591126 | Neuronal number and volume alterations in the neocortex of HIV infected individuals. |
| Q26830116 | On the role of NMR spectroscopy for characterization of antimicrobial peptides |
| Q52963013 | Optimization of the antimicrobial activity of magainin peptides by modification of charge. |
| Q34176123 | Osmotically induced membrane tension modulates membrane permeabilization by class L amphipathic helical peptides: nucleation model of defect formation. |
| Q36538861 | Peptide antimicrobial agents |
| Q37598400 | Peptide design for antimicrobial and immunomodulatory applications |
| Q48934369 | Phosphorylation of magainin-2 by protein kinase C and inhibition of protein kinase C isozymes by a synthetic analogue of magainin-2-amide |
| Q41826503 | Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives |
| Q34093320 | Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells |
| Q47805721 | Rational Design of Membrane-Pore-Forming Peptides |
| Q37026697 | Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens |
| Q91866702 | Rational design of novel amphipathic antimicrobial peptides focused on the distribution of cationic amino acid residues |
| Q68412242 | Relationship of promagainin to three other prohormones from the skin ofXenopus laevis: A different perspective |
| Q71743192 | Role of the leader and structural regions of prelantibiotic peptides as assessed by expressing nisin-subtilin chimeras in Bacillus subtilis 168, and characterization of their physical, chemical, and antimicrobial properties |
| Q73763373 | Secretory granule-cytoplasm relationships in serous glands of anurans: ultrastructural evidence and possible functional role |
| Q34680351 | Solid-state NMR investigation of the membrane-disrupting mechanism of antimicrobial peptides MSI-78 and MSI-594 derived from magainin 2 and melittin |
| Q52487161 | Spontaneous polymerization of the antibiotic peptide magainin 2. |
| Q24563530 | Squalamine: an aminosterol antibiotic from the shark |
| Q28830676 | Status, Antimicrobial Mechanism, and Regulation of Natural Preservatives in Livestock Food Systems |
| Q96303599 | Strategies in Translating the Therapeutic Potentials of Host Defense Peptides |
| Q28484282 | Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus |
| Q57018875 | Structural changes of spores of tree fungal pathogens after treatment with the designed antimicrobial peptide D2A21 |
| Q34179987 | Structure and dynamics of the antibiotic peptide PGLa in membranes by solution and solid-state nuclear magnetic resonance spectroscopy |
| Q34088952 | Structure and interactions of magainin antibiotic peptides in lipid bilayers: a solid-state nuclear magnetic resonance investigation |
| Q36277872 | Structure and orientation of the antibiotic peptide magainin in membranes by solid-state nuclear magnetic resonance spectroscopy |
| Q37325942 | Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin. |
| Q73413971 | Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity |
| Q41866978 | Structure-function relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities |
| Q52529061 | Studies of kinetics and equilibrium membrane binding of class A and class L model amphipathic peptides. |
| Q68486558 | Synthetic magainin analogues with improved antimicrobial activity |
| Q77796414 | The amphipathic helix concept: length effects on ideally amphipathic LiKj(i=2j) peptides to acquire optimal hemolytic activity |
| Q33789729 | The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their interactions with lipid membranes |
| Q37361213 | The roles of antimicrobial peptides in innate host defense |
| Q39062867 | The therapeutic applications of antimicrobial peptides (AMPs): a patent review |
| Q33267137 | Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins |
| Q47724682 | Traditional approaches to wound healing |
| Q30873013 | Ultrastructural patterns of secretory activity in poison cutaneous glands of larval and juvenile Dendrobates auratus (Amphibia, Anura). |
| Q41892359 | Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein |
| Q33789700 | Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes |
Search more.